CSL Behring

CSL Behring, headquartered in Ottawa, Ontario, is a global leader in the development and delivery of innovative therapies for rare and serious diseases, aiming to enhance the quality of life for patients. The company specializes in a wide range of treatments, particularly for immunodeficiency, autoimmune diseases, hereditary bleeding disorders, and alpha-1 antitrypsin deficiency.

Committed to advancing medical and scientific knowledge, CSL Behring supports investigator-initiated studies and recognizes emerging specialists through awards like the Heimburger Award. The organization prioritizes patient access to therapies, ensuring that individuals with rare conditions receive the necessary treatments without barriers.

Generated from the website